UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 19

of 'Treatment of relapsed or refractory acute lymphoblastic leukemia in adults'

19
TI
Inotuzumab ozogamicin in adults with relapsed or refractory CD22-positive acute lymphoblastic leukemia: a phase 1/2 study
AU
DeAngelo D, Stock W, Stein A, et al
SO
Blood Advances. 2017;1(15):1167.
 
AD